Preclinical and translational vaccine development for HIV and other candidate agents
Ended Awarded Last action
- Contract number
- 75N93022F00001
- Awardee
-
International Aids Vaccine Initiative Inc. UEI ZEJBC8JQM3P5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,013,603
Award facts
- Contract value 95% obligated
-
- $8,013,603.00 Current, with exercised options
- $8,398,301.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- New York, NY 10004, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Change Order | $3,358,279 | |
| Change Order | $209,011 | |
| Change Order | $471,590 | |
| Other Administrative Action | $0 | |
| Funding Only Action | $3,972,223 | |
| Original award | $2,500 |
About this award
This $8,398,301.00 cost-reimbursement delivery order was awarded on December 1, 2021 by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The award is part of NIAID's Preclinical And Translational Vaccine Development for HIV and Other Candidate Agents (PTVDS) program and will support IAVI's preclinical and translational vaccine development work for HIV and other infectious diseases through August 29, 2030. IAVI has multiple indefinite delivery/indefinite quantity (IDIQ) contracts with NIAID for these types of services. This specific award was not set aside for any socioeconomic program.
Quick answers
Who was awarded contract 75N93022F00001?
75N93022F00001 was awarded to International Aids Vaccine Initiative Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on December 1, 2021.
How much is contract 75N93022F00001 worth?
The government has obligated $8,013,603 on 75N93022F00001. Its potential value, with all options, is $8,398,301.
Is contract 75N93022F00001 an order under another contract?
Yes. 75N93022F00001 is a delivery order under 75N93022D00005, an indefinite delivery contract, on Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93022F00001 competed?
The extent of competition for 75N93022F00001 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award